News for Healthier Living

Breakthrough Clinical Trial Reveals Better Treatment for Advanced Classic Hodgkin Lymphoma

Updated results from a phase 3 clinical trial are expected to change the way advanced stage classic Hodgkin lymphoma (cHL) is treated. Details appear in a study published today in The New England Journal of Medicine. Drs. Kara Kelly of Roswell Park Comprehensive Cancer Center and Sharon Castellino of Children's Healthcare of Atlanta and Emory University School of Medicine/Winship Cancer Institute of Emory University served as pediatric leads of this important trial in children and adults with lymphoma.

October 16, 2024


October 19 2024

October 18 2024

October 17 2024

October 16 2024

October 15 2024

October 14 2024

October 13 2024

October 12 2024

October 11 2024

October 10 2024

October 9 2024

October 8 2024

October 7 2024

October 6 2024

October 5 2024